AMRN

NASDAQ 已收盘

Amarin Corporation

13.93 USD
-0.07-0.50%
盘后 13.95 +0.14%
2026-09-15
市值
$292.66M
市盈率
EPS
-1.30
股息率
52 周区间
12.96 – 20.90
成交量
41.10K
Beta
0.76
目标价
12.50
52W 低 12.9652W 高 20.90
价格走势

公司简介

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaborat...